1. From the Department of Clinical Pharmacology, Division of Ophthalmo-Pharmacology, and the
2. From the Department of Clinical Pharmacology, Division of Ophthalmo-Pharmacology, and the2Novartis Pharma AG, Basel, Switzerland.
3. From the Department of Clinical Pharmacology, Division of Ophthalmo-Pharmacology, and the3Center for Biomedical Engineering and Physics, Medical University of Vienna, Vienna, Austria; and